Browsing Over 990 Presentations
Navigating the waters of ES-SCLC (ID 1781)
Expert opinions on hot topics: A panel discussion (ID 1880)
Opening by the Chairperson (ID 1805)
Newly diagnosed advanced EGFRm NSCLC: What information will help improve our treatment decision? (ID 1806)
Planning the patient journey: How can we maximise all of the treatment opportunities? (ID 1807)
Exploring treatment options beyond progression (ID 1808)
Your opportunity to question the panel further: Audience Q & A (ID 1809)
Closing remarks (ID 1810)
Recent advances in metastatic prostate cancer management (ID 1881)
Expert Opinion on ‘PARP inhibitors as targeted therapy for personalized medicine’ - Panel Discussion (ID 1882)
